N4 Pharma PLC
LSE:N4P

Watchlist Manager
N4 Pharma PLC Logo
N4 Pharma PLC
LSE:N4P
Watchlist
Price: 0.45 GBX Market Closed
Market Cap: 3.7m GBX

Intrinsic Value

N4P doesn't have a meaningful market cap.

The intrinsic value of one N4P stock under the Base Case scenario is 0.01 GBX. Compared to the current market price of 0.45 GBX, N4 Pharma PLC is Overvalued by 98%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

N4P Intrinsic Value
0.01 GBX
Overvaluation 98%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
N4 Pharma PLC

What is Valuation History?
Compare N4P to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about N4P?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about N4 Pharma PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
N4 Pharma PLC

Current Assets 775.8k
Cash & Short-Term Investments 626k
Receivables 149.8k
Efficiency

Free Cash Flow Analysis
N4 Pharma PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
N4 Pharma PLC

Revenue
7.3k GBP
Operating Expenses
-1.2m GBP
Operating Income
-1.2m GBP
Other Expenses
162.5k GBP
Net Income
-1.1m GBP
Fundamental Scores

N4P Profitability Score
Profitability Due Diligence

N4 Pharma PLC's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
19/100
Profitability
Score

N4 Pharma PLC's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

N4P Solvency Score
Solvency Due Diligence

N4 Pharma PLC's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

N4 Pharma PLC's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

N4P Price Targets Summary
N4 Pharma PLC

There are no price targets for N4P.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for N4P is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one N4P stock?

The intrinsic value of one N4P stock under the Base Case scenario is 0.01 GBX.

Is N4P stock undervalued or overvalued?

Compared to the current market price of 0.45 GBX, N4 Pharma PLC is Overvalued by 98%.

Back to Top